Photo credit: www.investing.com

Applied Therapeutics Faces Securities Class Action Lawsuit

Investors have been made aware of a securities class action lawsuit directed at Applied Therapeutics (NASDAQ: APLT), following allegations of misleading practices that reportedly occurred during a key clinical trial for its drug candidate, govorestat. This lawsuit affects those who acquired securities of the company from January 3, 2024, until December 2, 2024, referred to as the Class Period. Legal representation is being sought through the law firm Kessler Topaz Meltzer & Check, LLP, with a deadline for lead plaintiff application set for February 18, 2025.

Allegations of Misconduct

The complaint suggests that the defendants engaged in misleading conduct by allegedly violating trial protocols and failing to adhere to good clinical practices for the drug candidate, govorestat. As a result, there are concerns about the potential rejection of trial data by the FDA during the New Drug Application process, posing substantial risks to investors and the company’s reputation.

Lead Plaintiff Process Explained

Investors impacted by these developments have the opportunity to apply for the role of lead plaintiff, representing the interests of all affected class members. Interested parties must do so by February 18, 2025. The lead plaintiff is typically selected based on financial interest in the case and serves to guide the litigation alongside approved legal counsel. Those who opt not to assume this role can still remain as class members without affecting their chances of recovering any potential losses.

About Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP operates across state and federal courts, focusing on class actions and working tirelessly to ensure accountability for corporate misconduct. With a proven track record of securing significant recoveries for defrauded investors and other affected parties, the firm is committed to protecting stakeholders from fraudulent activities and negligence.

Future Steps for Investors

Investors who believe they have incurred losses from their investments in Applied Therapeutics are encouraged to reach out to the law firm for further guidance and to discuss their options. The firm is dedicated to providing comprehensive legal support and ensuring that investor interests are effectively represented.

For more information, interested parties can visit Kessler Topaz Meltzer & Check, LLP’s website or contact the firm directly for assistance.

Source
www.investing.com